LPL Financial’s bluebird bio BLUE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q4
Sell
-4,304
Closed -$44.7K 5298
2024
Q3
$44.7K Sell
4,304
-5,274
-55% -$87.7K ﹤0.01% 5010
2024
Q2
$189K Sell
9,578
-1,874
-16% -$37.5K ﹤0.01% 4589
2024
Q1
$293K Buy
11,452
+10,108
+752% +$259K ﹤0.01% 4219
2023
Q4
$37.1K Buy
+1,344
New +$81.9K ﹤0.01% 4683
2021
Q3
Sell
-871
Closed -$361K 4334
2021
Q2
$361K Buy
+871
New +$345K ﹤0.01% 3440
2019
Q3
Sell
-415
Closed -$683K 3299
2019
Q2
$683K Buy
415
+7
+2% +$12.1K ﹤0.01% 2010
2019
Q1
$832K Buy
408
+27
+7% +$47.5K ﹤0.01% 1783
2018
Q4
$489K Buy
381
+2
+0.5% +$3.07K ﹤0.01% 2054
2018
Q3
$717K Sell
379
-39
-9% -$80.6K ﹤0.01% 1933
2018
Q2
$850K Buy
418
+17
+4% +$38.7K ﹤0.01% 1734
2018
Q1
$888K Sell
401
-10
-2% -$25.4K ﹤0.01% 1694
2017
Q4
$947K Buy
+411
New +$834K ﹤0.01% 1557

Other funds holding BLUE

LPL Financial's BLUE Position: Q4 2024 in Review

LPL Financial sold out of bluebird bio (BLUE) in Q4 2024, closing a stake of 4,304 shares — an estimated $44.7K sold.

LPL Financial first reported a position in BLUE in Q4 2017 and held it in 12 quarters. The position peaked at $947K in Q4 2017. 83 funds tracked by Wall St. Rank hold BLUE as of Q4 2024.

  • LPL Financial reported no remaining bluebird bio position as of Q4 2024 after selling out during the quarter.
  • LPL Financial sold 4,304 bluebird bio shares in Q4 2024, an estimated $44.7K.
  • LPL Financial first reported a position in bluebird bio in Q4 2017 and held it in 12 quarters.
  • LPL Financial's bluebird bio position peaked at $947K in Q4 2017.
  • 83 funds tracked by Wall St. Rank held bluebird bio as of Q4 2024.

Based on LPL Financial's 13F filing for Q4 2024, filed 11 Feb 2025.